| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |